COVID-19 is driving patients to seek telehealth solutions, and it won’t be a short-term boom.
A look at IP litigation in 2019 and the year ahead, and some advice on how medical device companies can safeguard their intellectual property.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
Many considerations should not be overlooked.
Access to the IVD market in China is lengthy and complicated.
Although an expensive and challenging regulatory market, Japan’s aging population offers plenty of opportunities for device companies.
It’s critical to understand the characteristics of this country’s market to determine the most effective steps.
‘Value’ is the common thread in PwC’s annual report on top health industry trends.
As the Internet of Things and the reimbursement environment transform the healthcare ecosystem, device manufacturers must position themselves to adapt.
Device companies will need to assess their business model in order to compete in an outcomes-based reimbursement environment.